Currently out of the existing stock ratings of David Rescott, 118 are a BUY (70.66%), 49 are a HOLD (29.34%).

David Rescott

Work Performance Price Targets & Ratings Chart

Analyst David Rescott, currently employed at BAIRD, carries an average stock price target met ratio of 61.23% that have a potential upside of 18.81% achieved within 168 days. Previously, David Rescott worked at TRUIST, OSCAR GRUSS.

David Rescott’s has documented 300 price targets and ratings displayed on 15 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on MDT, Medtronic PLC at 04-Jun-2026.

Wall Street Analyst David Rescott

Analyst best performing recommendations are on LIVN (LIVANOVA PLC).
The best stock recommendation documented was for NVRO (NEVRO CORP) at 10/15/2024. The price target of $5 was fulfilled within 2 days with a profit of $0.14 (2.72%) receiving and performance score of 13.62.

Average potential price target upside

of $60.92 (13.92%) on ISRG (INTUITIVE SURGICAL).
of $47.72 (20.37%) on PEN (PENUMBRA).
of $34.05 (35.16%) on IRTC (IRHYTHM TECHNOLOGIES).

MDT Medtronic PLC NVRO Nevro Corp PEN Penumbra IRTC iRhythm Technologies IRT Independence Realty Trust AXNX Axonics Modulation Technologies SIBN Si-Bone BSX Boston Scientific Corp INSP Inspire Medical Systems ISRG Intuitive Surgical LIVN LivaNova PLC NARI Inari Medical EW Edwards Lifesciences Corp MMSI Merit Medical Systems HAE Haemonetics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Joshua Jennings (TD COWEN)